NSW Pharmacy Trial

A NSW Government funded research study. Independently led by the University of Newcastle.

The NSW Pharmacy Trial was a large-scale research study that enabled appropriately trained community pharmacists to provide selected services under defined trial conditions. The Trial was designed to assess patient safety and the clinical outcomes of pharmacist-led models of care.

The Trial included three phases:

  1. Management of uncomplicated urinary tract infections (UTIs)
    (15 May 2023 to 31 May 2024)
  2. Resupply of the oral contraceptive pill (OCP)
    (27 September 2023 to 27 September 2024)
  3. Management of four minor skin conditions (exacerbations of mild to moderate atopic dermatitis, exacerbations of mild chronic plaque psoriasis, herpes zoster and impetigo)
    (19 July 2024 until 31 August 2025)

These services were delivered under strict clinical protocols and governance arrangements, with data collected to assess patient safety and support a comprehensive independent evaluation.

Independent evaluation

The NSW Pharmacy Trial was independently led and evaluated by the University of N​ewcastle in association with partner organisations.

The evaluation reports are independently authored academic reports. The findings and conclusions are those of the authors and do not represent a policy position of NSW Health.

Evaluation reports

The final independent evaluation report for the management of uncomplicated urinary tract infections (UTIs) and the resupply of the oral contraceptive pill (OCP) have now been completed, published and are available at the​ ​ University of Newcastle’s website.

The evaluation report for the remaining phase of the Trial will be finalised separately:

  • the management of four minor skin conditions (exacerbations of atopic dermatitis, exacerbations of chronic plaque psoriasis, herpes zoster and impetigo)

Contact us

For information related to the evaluation reports, please email the research team at NSWPharmacyTrial@newcastle.edu.au​​.

For NSW Health media enquiries, email media@health.nsw.gov.au. Please include your name and contact information in your message.​​​​​​​​

Current as at: Monday 1 June 2026
Contact page owner: Pharmaceutical Services